Law360, New York (March 22, 2016, 1:29 PM EDT) -- The U.S. Food and Drug Administration said Tuesday it will now require black-box warnings on immediate-release opioids highlighting the risk of “misuse, abuse, addiction, overdose and death,” to combat what the agency described as an epidemic of addiction.
Prescriptions including oxycodone, hydrocodone and morphine will now have to state that they are only for patients with severe enough pain to justify opioids and for which other treatments were not sufficient or tolerated, the FDA said. The update will also clarify dosage instructions, including how much should be given initially, how that dosage should be changed and a warning against suddenly stopping...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!